Atyr Pharma Inc (ATYR) SEC Filings — 2025
9 SEC filings for Atyr Pharma Inc (ATYR) in 2025.
Filings
- Atyr Pharma Faces Nasdaq Delisting Notice — 8-K · Dec 5, 2025
- aTYR Pharma's Losses Widen Amid Soaring R&D Costs — 10-Q · Nov 6, 2025
- aTYR PHARMA INC Files 8-K Report — 8-K · Sep 15, 2025
- Atyr Pharma Files 8-K/A Amendment — 8-K/A · Aug 8, 2025
- aTYR PHARMA Reports Flat Revenue, Widening Net Loss in Q2 — 10-Q · Aug 7, 2025
- Atyr Pharma Files Q1 2025 10-Q — 10-Q · May 7, 2025
- Atyr Pharma Announces Board Changes and Shareholder Votes — 8-K · May 6, 2025
- Atyr Pharma Files DEF 14A on Executive Compensation — DEF 14A · Mar 19, 2025
- Atyr Pharma Files 2024 10-K — 10-K · Mar 13, 2025